{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT02692313",
            "orgStudyIdInfo": {
                "id": "HP-00068487"
            },
            "organization": {
                "fullName": "University of Maryland, Baltimore",
                "class": "OTHER"
            },
            "briefTitle": "Dose Response of Epinephrine",
            "officialTitle": "Hypoglycemia Associated Autonomic Dysfunction Dose Response of Epinephrine",
            "acronym": "Epineprhine",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "dose-response-of-epinephrine"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2016-06"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-02",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2016-02-10",
            "studyFirstSubmitQcDate": "2016-02-22",
            "studyFirstPostDateStruct": {
                "date": "2016-02-26",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2024-03-05",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Stephen N. Davis, MBBS",
                "investigatorTitle": "Chairman of Medicine",
                "investigatorAffiliation": "University of Maryland, Baltimore"
            },
            "leadSponsor": {
                "name": "University of Maryland, Baltimore",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Vanderbilt University",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true
        },
        "descriptionModule": {
            "briefSummary": "Epinephrine is the principal physiologic defense against hypoglycemia in type 1 and longer duration type 2 DM. Despite this, it is unknown how epinephrine regulates in-vivo endothelial function and atherothrombotic balance in humans. The specific aim of our study will be to determine the dose response effects of the key ANS counterregulatory hormone epinephrine on endothelial function, fibrinolytic balance and pro-atherogenic inflammatory mechanisms in healthy humans."
        },
        "conditionsModule": {
            "conditions": [
                "Diabetes Complications"
            ],
            "keywords": [
                "epinephrine",
                "counterregulation",
                "dose responses"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "PARTICIPANT"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 32,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Saline infusion",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Hyperinsulinemic euglycemic glucose clamp with saline infusion",
                    "interventionNames": [
                        "Other: Saline infusion"
                    ]
                },
                {
                    "label": "Epinephrine infusion-0.015ug/kg/min",
                    "type": "EXPERIMENTAL",
                    "description": "Hyperinsulinemic euglycemic glucose clamp with epinephrine infusion of 0.015 ug/kg/min",
                    "interventionNames": [
                        "Drug: Epinephrine"
                    ]
                },
                {
                    "label": "Epinephrine infusion-0.03 ug/kg/min",
                    "type": "EXPERIMENTAL",
                    "description": "Hyperinsulinemic euglycemic glucose clamp with epinephrine infusion of 0.03 ug/kg/min",
                    "interventionNames": [
                        "Drug: Epinephrine"
                    ]
                },
                {
                    "label": "Epinephrine infusion-0.06 ug/kg/min",
                    "type": "EXPERIMENTAL",
                    "description": "Hyperinsulinemic euglycemic glucose clamp with epinephrine infusion of 0.06 ug/kg/min",
                    "interventionNames": [
                        "Drug: Epinephrine"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Epinephrine",
                    "description": "Dose response of epinephrine infusion",
                    "armGroupLabels": [
                        "Epinephrine infusion-0.015ug/kg/min",
                        "Epinephrine infusion-0.03 ug/kg/min",
                        "Epinephrine infusion-0.06 ug/kg/min"
                    ],
                    "otherNames": [
                        "Adrenaline"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Saline infusion",
                    "description": "Placebo",
                    "armGroupLabels": [
                        "Saline infusion"
                    ],
                    "otherNames": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Flow mediated dilation (FMD) of the brachial artery",
                    "description": "Measurements of FMD will be taken at baseline (pre intervention) and end of glucose clamp (post intervention) and the maximal % change determined",
                    "timeFrame": "From baseline (pre glucose clamp) to end of experiment (time 240 minutes- 2 hours post intervention (glucose clamp))"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* healthy controls age 18-55 yr.\n* Body mass index \\>21 kg \u00b7 m-2\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding women\n* Subjects unwilling or unable to comply with approved contraception measures\n* Subjects unable to give voluntary informed consent\n* Subjects on anticoagulant drugs, anemic or with known bleeding diatheses\n* Subjects with a history of severe, uncontrolled hypertension, heart disease, cerebrovascular incidents\n* Current tobacco use\n* Subjects with any known allergies to any of the study medications being used\n\nPhysical Exam Exclusion Criteria\n\n* Uncontrolled severe hypertension (i.e., blood pressure greater than 160/100)\n* Clinically significant cardiac abnormalities (e.g. heart failure, arrhythmia)\n* Pneumonia treatment or hospitalization within 2 weeks prior to enrollment (study visit)\n* Hepatic failure / jaundice\n* Renal failure\n* Cerebrovascular accident occurrence or hospitalization within 4 weeks prior to enrollment\n* Fever greater than 38.0 degrees C\n\nScreening Laboratory Tests Exclusion Criteria\n\n* Hematocrit lower than 32 %\n* White blood cell (WBC) count lower than 3 thou/ul or greater than 14 thou/ul\n* Liver function tests: serum glutamic oxaloacetic transaminase (SGOT) and serum glutamic-pyruvic transaminase (SGPT) greater than twice upper limit of normal range\n* Alkaline phosphatase greater than 150U/L\n* Total bilirubin (TBil) greater than 2 mg/dl\n* Estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73 m2\n* Positive human immunodeficiency virus (HIV), Hepatitis B or Hepatitis C\n* Any abnormal cardiac response during multi-stage exercise test (if over 40 years of age)",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Maka Siamashvili, MD",
                    "role": "CONTACT",
                    "phone": "410-706-5623",
                    "email": "msiamashvili@medicine.umaryland.edu"
                },
                {
                    "name": "Maia Mikeladze, MD",
                    "role": "CONTACT",
                    "phone": "410-706-5626",
                    "email": "mmikeladze@medicine.umaryland.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Stephen Davis, MBBS",
                    "affiliation": "University of Maryland, Baltimore",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Maryland, Baltimore",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Maka Siamashvili, MD",
                            "role": "CONTACT",
                            "phone": "410-706-5643"
                        },
                        {
                            "role": "CONTACT",
                            "phone": "410-706-5636"
                        },
                        {
                            "name": "Stephen N Davis, MBBS",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000048909",
                    "term": "Diabetes Complications"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M26004",
                    "name": "Diabetes Complications",
                    "asFound": "Diabetes Complications",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10053",
                    "name": "Hypoglycemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M4643",
                    "name": "Autonomic Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27979",
                    "name": "Primary Dysautonomias",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000004837",
                    "term": "Epinephrine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000316",
                    "term": "Adrenergic alpha-Agonists"
                },
                {
                    "id": "D000000322",
                    "term": "Adrenergic Agonists"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000318",
                    "term": "Adrenergic beta-Agonists"
                },
                {
                    "id": "D000001993",
                    "term": "Bronchodilator Agents"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000018927",
                    "term": "Anti-Asthmatic Agents"
                },
                {
                    "id": "D000019141",
                    "term": "Respiratory System Agents"
                },
                {
                    "id": "D000009184",
                    "term": "Mydriatics"
                },
                {
                    "id": "D000013566",
                    "term": "Sympathomimetics"
                },
                {
                    "id": "D000014662",
                    "term": "Vasoconstrictor Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7992",
                    "name": "Epinephrine",
                    "asFound": "Placement",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30371",
                    "name": "Racepinephrine",
                    "relevance": "LOW"
                },
                {
                    "id": "M211043",
                    "name": "Epinephryl borate",
                    "relevance": "LOW"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M3668",
                    "name": "Adrenergic alpha-Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M3673",
                    "name": "Adrenergic Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M3670",
                    "name": "Adrenergic beta-Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M5269",
                    "name": "Bronchodilator Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20963",
                    "name": "Anti-Asthmatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21137",
                    "name": "Respiratory System Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M12139",
                    "name": "Mydriatics",
                    "relevance": "LOW"
                },
                {
                    "id": "M16345",
                    "name": "Sympathomimetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M17409",
                    "name": "Vasoconstrictor Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "VaCoAg",
                    "name": "Vasoconstrictor Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}